Inflammation and macular oedema after pars plana vitrectomy

Vito Romano, Martina Angi, Fabrizio Scotti, Renata Del Grosso, Davide Romano, Francesco Semeraro, Paolo Vinciguerra, Ciro Costagliola, Mario R. Romano

Research output: Contribution to journalArticlepeer-review


Cystoid macular oedema (CMO) is a major cause of reduced vision following intraocular surgery. Although the aetiology of CMO is not completely clarified, intraocular inflammation is known to play a major role in its development. The macula may develop cytotoxic oedema when the primary lesion and fluid accumulation occur in the parenchymatous cells (intracellular oedema) or vasogenic oedema when the primary defect occurs in the blood-retinal barrier and leads to extracellular fluid accumulation (extracellular oedema). We report on the mechanisms of CMO formation after pars plana vitrectomy and associated surgical procedures and discuss possible therapeutic approaches.

Original languageEnglish
Article number971758
JournalMediators of Inflammation
Publication statusPublished - 2013

ASJC Scopus subject areas

  • Immunology
  • Cell Biology

Fingerprint Dive into the research topics of 'Inflammation and macular oedema after pars plana vitrectomy'. Together they form a unique fingerprint.

Cite this